US lawmakers launch investigation into FDA approval and price of new Alzheimer's drug
By Lemuel in News
Updated 3 years ago
Two House committees have launched an investigation into the approval and pricing of the Alzheimer's disease drug aducanumab, made by the company Biogen and sold under the brand name Aduhelm.